Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Lustgarten Foundation for Pancreatic Cancer Research is the world's largest private funder of pancreatic cancer research, dedicated to advancing scientific breakthroughs that lead to earlier detection and better treatments. The organization supports a network of dedicated research laboratories, most notably the Lustgarten Foundation Pancreatic Cancer Research Laboratory at Cold Spring Harbor Laboratory, led by Dr. David Tuveson. Their research strategy focuses on high-impact areas such as patient-derived organoids for personalized medicine, the development of KRAS-targeted therapies, and the identification of early detection biomarkers. By fostering collaborations between top-tier academic institutions like Johns Hopkins and MIT, the foundation accelerates the translation of basic science into clinical trials. Notably, 100% of all public donations are directed toward research initiatives, as administrative costs are covered by separate funding.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lustgarten Pancreatic Cancer Research Laboratory.